Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
ReShape Lifesciences Inc (ReShape) formerly Obalon Therapeutics Inc, designs, develops and commercializes minimally invasive medical devices to treat obesity and metabolic diseases. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. ReShape Vest system is a implanted device allows weight reduction while keeping the stomach in place. It provides ReShapeCare virtual health coaching programme, which encourages healthy lifestyle modifications for all patients undergoing medically assisted weight reduction, and ReShape Diabetes Bloc-Stim Neuromodulation, a preclinical technology being developed for the treatment of type 2 diabetes mellitus. ReShape is headquartered in San Clemente, California, the US.
Products and Services
Products | Brands |
---|---|
Lap-Band System | ReShape Vest |
ReShape Calibration Tubes | |
ReShapeCare | |
XYZ | |
XYZ | |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In September, the company entered into an agreement with Biorad Medisys for Obalon Gastric balloon system. |
2023 | Contracts/Agreements | In June, the company entered into an agreement with Hive Medical to Manage Prospective Lap-Band Leads From Initial Contact Through Surgical Consultation. |
2021 | Acquisitions/Mergers/Takeovers | In June, the company merged with Obalon Therapeutics Inc. |
Competitor Comparison
Key Parameters | ReShape Lifesciences Inc | Acutus Medical Inc | Morphic Medical Inc | Orexigen Therapeutics Inc |
---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America |
City | San Clemente | Carlsbad | Boston | La Jolla |
State/Province | California | California | Massachusetts | California |
No. of Employees | 40 | 225 | - | - |
Entity Type | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Dan W. Gladney | Chairman | Executive Board | 2015 | - |
Paul F. Hickey | President; Chief Executive Officer | Senior Management | 2022 | - |
Thomas Stankovich | Chief Financial Officer | Senior Management | 2019 | 61 |
Tom Stankovich | Chief Financial Officer | Senior Management | - | - |
Dov Gal | Vice President - Regulatory Clinical Quality; Chief Compliance Officer | Senior Management | 2019 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer